FDA Panel Rejects MDMA-Assisted Therapy For PTSD
An FDA advisory panel has recommended that the agency not approve the use of MDMA-assisted therapy as a treatment for PTSD.
Source: forbes.com
📰 Psychedelic Studies News
Page 2 - Psychedelic Studies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Psychedelic Studies. Real-time updates on events, politics, business and more.
FDA Advisers Overwhelmingly Oppose Approval of MDMA As a Psychotherapeutic Catalyst
The panel's recommendation, based on several concerns about two clinical trials, is a serious setback for a promising PTSD treatment.
Source: reason.com
Psychoactive drugs are having a moment. The FDA will soon weigh in
MDMA is part of a new wave of psychoactive drugs that show great potential for treating conditions such as severe depression and PTSD.
Source: orlandosentinel.com
Psychoactive drugs are having a moment. The FDA will soon weigh in
MDMA is part of a new wave of psychoactive drugs that show great potential for treating conditions such as severe depression and PTSD.
Source: lowellsun.com
Panel rejects psychedelic drug MDMA as PTSD treatment in possible setback for advocates
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.
United States Melissa Decker Barone Elizabeth Joniak Rajesh Narendran University Of Pittsburgh Multidisciplinary Association For Psychedelic
Source: cbs6albany.com
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
WASHINGTON — Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD, handing a potentially major setback to psychedelic advocates who hope to win a landmark federal approval and bring the banned drugs into the medical mainstream. The panel
United States Kelley Odonnell Tiffanyr Farchione Drug Administration York University Multidisciplinary Association For Psychedelic
Source: triblive.com
Panel rejects psychedelic drug MDMA as PTSD treatment in possible setback for advocates
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.
United States Melissa Decker Barone Elizabeth Joniak Rajesh Narendran Drug Administration Institute For Clinical
Source: local12.com
Panel rejects psychedelic drug MDMA as PTSD treatment in possible setback for advocates
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.
United States Rajesh Narendran Elizabeth Joniak Melissa Decker Barone Drug Administration Institute For Clinical
Source: wpde.com
Panel rejects psychedelic drug MDMA as PTSD treatment in possible setback for advocates
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.
United States Elizabeth Joniak Rajesh Narendran Melissa Decker Barone Multidisciplinary Association For Psychedelic Department Of Veterans Affairs
Source: wwmt.com
Panel rejects psychedelic drug MDMA as PTSD treatment in possible setback for advocates
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.
United States Melissa Decker Barone Rajesh Narendran Elizabeth Joniak Department Of Veterans Affairs Multidisciplinary Association For Psychedelic
Source: katu.com